DRYDEN CAPITAL, LLC European Biotech Acquisition Corp. Transaction History

DRYDEN CAPITAL, LLC portfolio value:

$0
portfolio value

DRYDEN CAPITAL, LLC quarter portfolio value change:

-36.04%
quarter

European Biotech Acquisition Corp. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -15K shares -1K $0.1 0
Q2 2022 share 0.00% 0 shares -2K $0.15 15K
Q1 2022 share 0.00% 0 shares -6K $0.2 15K
Q4 2021 share Increase 0.00% 15K shares 9K $0.58 15K